CIK: 0001388551
申报总市值
US$402.4万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RZLT | Rezolute INC | 股票-其他 | 72.60% | — | +21.61% | |
| 2 | GLD | Spdr Gold Shares | ETF-避险与商品 | 15.32% | +17.00% | +281.51% | |
| 3 | BRK-B | Berkshire Hathaway Inc-cl B | 股票-其他 | 3.12% | +0.32% | +35.33% | |
| 4 | ELVN | Enliven Therapeutics INC | 股票-其他 | 2.67% | — | — | |
| 5 | BRD1EUR | Mind Medicine Mindmed INC | 股票-其他 | 2.24% | -4.91% | EXIT | |
| 6 | CMPX | Compass Therapeutics INC | 股票-其他 | 1.15% | -3.70% | EXIT | |
| 7 | BCAX | Bicara Therapeutics INC | 股票-其他 | 1.03% | — | — | |
| 8 | KYTX | Kyverna Therapeutics INC | 股票-其他 | 0.72% | -0.09% | — | |
| 9 | LXEO | Lexeo Therapeutics INC | 股票-其他 | 0.71% | -1.25% | -2.91% | |
| 10 | IKT | Inhibikase Therapeutics INC | 股票-其他 | 0.32% | -0.17% | — | |
| 11 | CNTX | Context Therapeutics INC | 股票-其他 | 0.12% | -0.63% | EXIT |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | GLD | Spdr Gold Shares | +8% | +281.51% | 加仓 |
| 2 | ELVN | Enliven Therapeutics INC | +2.7% | NEW | 新建仓 |
| 3 | CNTX | Context Therapeutics INC | -0.1% | — | 不变 |
| 4 | KYTX | Kyverna Therapeutics INC | -0.2% | — | 不变 |
| 5 | TORCEUR | Adicet Bio INC | -0.3% | EXIT | 清仓 |
| 6 | IKT | Inhibikase Therapeutics INC | -0.4% | — | 不变 |
| 7 | CMPX | Compass Therapeutics INC | -0.5% | — | 不变 |
| 8 | LXEO | Lexeo Therapeutics INC | -0.5% | -2.91% | 减仓 |
| 9 | CRDF | Cardiff Oncology INC | -0.8% | EXIT | 清仓 |
| 10 | BRD1EUR | Mind Medicine Mindmed INC | -1.7% | — | 不变 |
| 11 | BRK-B | Berkshire Hathaway Inc-cl B | -1.8% | +35.33% | 加仓 |
| 12 | BCAX | Bicara Therapeutics INC | -1.8% | — | 不变 |
| 13 | RZLT | Rezolute INC | -2.7% | +21.61% | 加仓 |